Fever of Unknown Origin Due to Zoonoses

Infectious Disease Clinics of North America

Volumn 21, Issue 4, 2007, Pages 963-996

  Cleri, Dennis J ^a,b   Ricketti, Anthony J ^a,b   Vernaleo, John R ^c  

^a ST FRANCIS MEDICAL CENTER   (United States)

^b SETON HALL UNIVERSITY   (United States)

^c WYCKOFF HEIGHTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPHOTERICIN B LIPID COMPLEX; ANTIBIOTIC AGENT; AZATHIOPRINE; BENZNIDAZOLE; CHLOROQUINE; CLARITHROMYCIN; DOXYCYCLINE; FLUCONAZOLE; IMMUNOGLOBULIN; INDINAVIR; INFLIXIMAB; ITRACONAZOLE; KETOCONAZOLE; MEGLUMINE ANTIMONATE; MILTEFOSINE; NIFURTIMOX; NITAZOXANIDE; PAROMOMYCIN; PENICILLIN G; PRAZIQUANTEL; RIFAMPICIN; ROXITHROMYCIN; SAQUINAVIR; SMALLPOX VACCINE; SPIRAMYCIN; STEROID; STIBOGLUCONATE SODIUM; UNINDEXED DRUG; VIRUS VACCINE;

ACANTHAMEBIASIS; ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMEBIASIS; AMOEBA (LIFE CYCLE STAGE); ANIMAL DISEASE; ANTHRAX; ANTIBIOTIC RESISTANCE; BACILLUS ANTHRACIS; BARTONELLA; BIOLOGICAL WARFARE; BLOOD TRANSFUSION; BRUCELLOSIS; CAT SCRATCH DISEASE; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM DISEASE; CHAGAS DISEASE; CHIKUNGUNYA ALPHAVIRUS; CLINICAL FEATURE; COLORADO TICK FEVER; COLTIVIRUS; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM; DIAGNOSTIC TEST; DIFFERENTIAL DIAGNOSIS; DISEASE TRANSMISSION; DRUG CHOICE; ENDOCARDITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC ENCEPHALITIS; FRANCISELLA TULARENSIS; FUSOBACTERIACEAE INFECTION; HAVERHILL FEVER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOMELESSNESS; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERREACTIVE MALARIAL SPLENOMEGALY; IMMUNE DEFICIENCY; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INCUBATION TIME; JAPANESE ENCEPHALITIS VIRUS; LABORATORY DIAGNOSIS; LEISHMANIA; LEISHMANIA BRAZILIENSIS; LEISHMANIA TROPICA; MALARIA; MENINGOENCEPHALITIS; MIMIVIRUS; MONKEYPOX; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARASITE TRANSMISSION; PATHOGENESIS; PHLEBOVIRUS; PLAGUE; PLASMODIUM; POLYMERASE CHAIN REACTION; PYREXIA IDIOPATHICA; RABBIT FEVER; RAT BITE FEVER; REVIEW; RHEUMATOID ARTHRITIS; SCHISTOSOMA; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMA INTERCALATUM; SCHISTOSOMA JAPONICUM; SCHISTOSOMA MANSONI; SCHISTOSOMA MEKONGI; SCHISTOSOMIASIS; SIMIAN IMMUNODEFICIENCY VIRUS; SKIN LEISHMANIASIS; SPIRILLUM; SPIRILLUM MINUS; SPLENOMEGALY; STEROID THERAPY; STREPTOBACILLUS MONILIFORMIS; TOSCANA VIRUS; TRYPANOSOMA CRUZI; VIBRIO PARAHAEMOLYTICUS; VIBRIO VULNIFICUS; VICERAL LARVA MIGRANS; VIRUS; VIRUS DIAGNOSIS; VIRUS INFECTION; VIRUS TRANSMISSION; VISCERAL LEISHMANIASIS; WEST NILE FLAVIVIRUS; XENODIAGNOSIS; YERSINIA PESTIS; ZOONOSIS;

ANIMALS; BACTERIAL INFECTIONS; FEVER OF UNKNOWN ORIGIN; HUMANS; PARASITIC DISEASES; VIRUS DISEASES; ZOONOSES;

EID: 36448986727     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2007.08.009     Document Type: Review

References (152)

1. Woolhouse M.E.J., and Gowtage-Sequeria S. Host range and emerging and reemerging pathogens. Emerg Infect Dis 11 (2005) 1842-1847
2. Mackowiak P.A., and Durack D.T. Fever of unknown origin. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 6th edition vol. 1 (2005), Elsevier Churchill Livingston, Philadelphia 718-729
3. Demma L.J., Vanderford T.H., Logsdon Jr. J.M., et al. Evolution of the uniquely adaptable lentiviral envelope in a natural reservoir host. Retrovirology 3 (2006) 19
4. Vande Woude S., and Apetrei C. Going wild: lessons from naturally occurring T-lymphotropic lentiviruses. Clin Microbiol Rev 19 (2006) 728-762
5. Switzer W.M., Bhullar V., Shanmugam V., et al. Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates. J Virol 78 (2004) 2780-2789
6. Reynolds S.J., Bessong P.O., and Quinn T.C. Human retroviral infections in the tropics. In: Guerrant R.L., Walker D.H., and Weller P.F. (Eds). Tropical infectious diseases-principles, pathogens, practice. 2nd edition vol. 1 (2006), Elsevier Churchill Livingston, Philadelphia 852-883
7. Peeters M., Courgnaud V., Abela B., et al. Risk to human health from a plethora of simian immunodeficiency viruses in primate bushmeat. Emerg Infect Dis 8 (2002) 451-457
8. Jeronimo S.M.B., De Queiroz Sousa A., and Pearson R.D. Leishmaniasis. In: Guerrant R.L., Walker D.H., and Weller P.F. (Eds). Tropical infectious diseases-principles, pathogens, practice. 2nd edition vol. 2 (2006), Elsevier Churchill Livingston, Philadelphia 1095-1113
9. Centers for Disease Control and Prevention. Two cases of visceral leishmaniasis in U.S. military personnel-Afghanistan, 2002-2004. MMWR Morb Mortal Wkly Rep 53 (2004) 265-268
10. Cardo L.J. Leishmania: risk to the blood supply. Transfusion 46 (2006) 1641-1645
11. Harms G., and Feldmeier H. The impact of HIV infection on tropical diseases. Infect Dis Clin North Am 19 (2005) 121-135
12. Cunha B.A. Fever of unknown origin in HIV/AIDS patients. Drugs Today (Barc) 35 (1999) 429-434
13. Barreto-de-Souza V., Pacheco G.J., Silva A.R., et al. Increased leishmania replication in HIV-1-infected macrophages is mediated by tat protein through cyclooxygenase-2 expression and prostaglandin E2 synthesis. J Infect Dis 194 (2006) 846-854
14. Nigro L., Rizzo M.L., Vancheri C., et al. CCR5 and CCR3 expression on TCD3+ lymphocytes from HIV/leishmania co-infected subjects. Med Microbiol Immunol 196 (2007) 253-255 [Epub ahead of print]
15. Gaskin A.A., Schantz P., Jackson J., et al. Visceral leishmaniasis in a New York foxhound kennel. J Vet Intern Med 16 (2002) 34-44
16. Duprey Z.H., Steurer F.J., Rooney J.A., et al. Canine visceral leishmaniasis, United States and Canada 2000-2003. Emerg Infect Dis 12 (2006) 440-446
17. Voutsinas D., Foudoulaki L., Sofroniadou K., et al. Visceral leishmaniasis in a patient with acquired hypogammaglobulinemia. Eur J Intern Med 12 (2001) 127-129
18. Masedo Gonzalez A., Barbero Allende J.M., Perez-Carreras M., et al. Intestinal leishmaniasis and Sezary syndrome: endoscopic diagnosis. Gastroenterol Hepatol 29 (2006) 546-550
19. Pittalis S., Nicastri E., Spinazzola F., et al. Leishmania infantum leishmaniasis in corticosteroid-treated patients. BMC Infect Dis 6 (2006) 177
20. Fabre S., Gibert C., Lechiche C., et al. Visceral leishmaniasis infection in a rheumatoid arthritis patient treated with infliximab. Clin Exp Rheumatol 23 (2005) 891-892
21. Garcia-Cordoba F., Ortuno F.J., Segovia M., et al. Fatal visceral leishmaniasis, with massive bone-marrow infection, in an immunosuppressed but HIV-negative Spanish patient, after the initiation of treatment with meglumine antimoniate. Ann Trop Med Parasitol 99 (2005) 125-130
22. Herrejon A., Cervera A., Macia M., et al. Bronchioalveolar adenoma associated with bronchiolitis obliterans and leishmaniasis with lung involvement in acquired immunodeficiency syndrome. Arch Bronconeumol 41 (2005) 233-235
23. Mofredj A., Guerin J.M., Leibinger F., et al. Visceral leishmaniasis with pericarditis in an HIV-infected patient. Scand J Infect Dis 34 (2002) 151-153
24. Cnudde F., Raccurt C., Boulard F., et al. Diffuse cutaneous leishmaniasis with visceral dissemination in an AIDS patient in Guadeloupe, West Indies. AIDS 8 (1994) 559-560
25. Boumis E., Chinello P., Della Rocca C., et al. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient. Int J STD AIDS 17 (2006) 351-353
26. Mellor-Pita S., Yebra-Bango M., Tutor de Ureta P., et al. Polyarthritis caused by Leishmania in a patient with human immunodeficiency virus. Clin Exp Rheumatol 22 (2004) 131
27. Meenken C., van Agtmael M.A., Ten Kate R.W., et al. Fulminant ocular leishmaniasis in an HIV-1 -positive patient. AIDS 18 (2004) 1485-1486
28. Ranieri R., Veronelli A., Santambrogio C., et al. Subclinical hypothyroidism in a patient affected by advanced AIDS and visceral leishmaniasis. Scand J Infect Dis 37 (2005) 935-937
29. Navarro M., Bonet J., Monal J., et al. Secondary amyloidosis with irreversible acute renal failure caused by visceral leishmaniasis in a patient with AIDS. Nefrologia 26 (2006) 745-746
30. Walker M., Kublin J.G., and Zunt J.R. Parasitic central nervous system infections in immunocompromised hosts: malaria, microsporidiosis, leishmaniasis, and African trypanosomiasis. Clin Infect Dis 42 (2006) 115-125 [Epub 2005 Nov 23]
31. Posada-Vergara M.P., Lindoso J.A., Tolezano J.E., et al. Tegumentary leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome in 2 patients with AIDS. J Infect Dis 192 (2005) 1819-1822
32. Cascio A., Colomba C., Antinori S., et al. Pediatric visceral leishmaniasis in western Sicily, Italy: a retrospective analysis of 111 cases. Eur J Clin Microbiol Infect Dis 21 (2002) 277-282
33. Pagliano P., Carannante N., Rossi M., et al. Visceral leishmaniasis in pregnancy: a case series and a systematic review of the literature. J Antimicrob Chemother 55 (2005) 229-233 [Epub 2005 Jan 13]
34. Singh S. New developments in diagnosis of leishmaniasis. Indian J Med Res 123 (2006) 311-330
35. Savoia D., Allice T., and Tovo P.A. Antileishmanial activity of HIV protease inhibitors. Int J Antimicrob Agents 26 (2005) 92-94
36. Mira J.A., Corzo J.E., Rivero A., et al. Frequency of visceral leishmaniasis relapses in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy. Am J Trop Med Hyg 70 (2004) 298-301
37. Kirchhoff L.V. American trypanosomiasis (Chagas' disease). In: Guerrant R.L., Walker D.H., and Weller P.F. (Eds). Tropical infectious diseases-principles, pathogens, practice. 2nd edition vol. 2 (2006), Elsevier Churchill Livingston, Philadelphia 1082-1094
38. De Nishioka S.A., Gyorkos T.W., Joseph L., et al. Tattooing and transfusion-transmitted diseases in Brazil: a hospital-based cross-sectional matched study. Eur J Epidemiol 18 (2003) 441-449
39. Concetti H., Retegui M., Perez G., et al. Chagas disease of the cervix uteri in a patient with acquired immunodeficiency syndrome. Hum Pathol 31 (2000) 120-122
40. Sartori A.M., Caiaffa-Filho H.H., Berzerra R.C., et al. Exacerbation of HIV viral load simultaneous with asymptomatic reactivation of chronic Chagas' disease. Am J Trop Med Hyg 67 (2002) 521-523
41. Iliovich E., Lopez R., Kum M., et al. Spontaneous chagasic peritonitis in a patient with AIDS. Medicina (B Aires) 58 5 Pt 1 (1998) 507-508
42. Sartori A.M., Sotto M.N., Braz L.M., et al. Reactivation of Chagas disease manifested by skin lesions in a patient with AIDS. Trans R Soc Trop Med Hyg 93 (1999) 631-632
43. Rosemberg S., Chaves C.J., Higuchi M.L., et al. Fatal meningoencephalitis caused by reactivation of Trypansoma cruzi infection in a patient with AIDS. Neurology 42 3 Pt 1 (1992) 640-642
44. Lambert N., Mehta B., Walters R., et al. Chagasic encephalitis as the initial manifestation of AIDS. Ann Intern Med 144 (2006) 941-943
45. Yoo T.W., Mlikotic A., Cornford M.E., et al. Concurrent cerebral American trypanosomiasis and toxoplasmosis in a patient with AIDS. Clin Infect Dis 39 (2004) e30-e34 [Epub 2004 Jul 28]
46. Pimentel P.C., Handfas B.W., and Carmignani M. Trypansoma cruzi meningoencephalitis in AIDS mimicking cerebral metastases: case report. Arq Neuropsiquiatr 54 (1996) 102-106
47. Sartori A.M., Neto J.E., Nunes E.V., et al. Trypansoma cruzi parasitemia in chronic Chagas disease: comparison between human immunodeficiency virus (HIV)-positive and HIV-negative patients. J Infect Dis 186 (2002) 872-875 [Epub 2002 Aug 9]
48. Lages-Silva E., Ramirez L.E., Silva-Vergara M.L., et al. Chagasic meningoencephalitis in a patient with acquired immunodeficiency syndrome: diagnosis, follow-up, and genetic characterization of Trypansoma cruzi. Clin Infect Dis 34 (2002) 118-123 [Epub 2001 Nov 26]
49. Viotti R., Vigliano C., Lococo B., et al. Long-term cardiac outcomes of treating chronic Chagas disease with benznidazole versus no treatment: a nonrandomized trial. Ann Intern Med 144 (2006) 724-734
50. Corti M., and Yampolsky C. Prolonged survival and immune reconstitution after chagasic meningoencephalitis in a patient with acquired immunodeficiency syndrome. Rev Soc Bras Med Trop 39 (2006) 85-88 [Epub 2006 Feb 23]
51. King C.H. Schistosomiasis. In: Guerrant R.L., Walker D.H., and Weller P.F. (Eds). Tropical infectious diseases-principles, pathogens, practice. 2nd edition vol. 2 (2006), Elsevier Churchill Livingston, Philadelphia 1341-1348
52. Secor W.E. Interactions between schistosomiasis and the infection with HIV-1. Parasite Immunol 28 (2006) 597-603
53. Kjetland E.F., Ndhlovu P.D., Gomo E., et al. Association between genital schistosomiasis and HIV in rural Zimbabwean women. AIDS 20 (2006) 593-600
54. Payet B., Chaumentin G., Boyer M., et al. Prolonged latent schistosomiasis diagnosed 38 years after infestation in a HIV patient. Scand J Infect Dis 38 (2006) 572-575
55. de Silva S., Walsh J., and Brown M. Symptomatic Schistosoma mansoni infection as an immune restoration phenomenon in a patient receiving antiretroviral therapy. Clin Infect Dis 42 (2006) 303-304
56. Walker M., and Zunt J.R. Parasitic central nervous system infections in immunocompromised hosts. Clin Infect Dis 40 (2005) 1005-1015 [Epub 2005 Mar 2]
57. Kallestrup P., Zinyama R., Gomo E., et al. Schistosomiasis and HIV in rural Zimbabwe: efficacy of treatment of schistosomiasis in individuals with HIV coinfection. Clin Infect Dis 42 (2006) 1781-1789
58. White Jr. A.C. Cryptosporidiosis (Cryptosporidium hominis, Cryptosporidium parvum) and other species. In: Mandell G.L., Bennett J.E., and Dolin R. (Eds). Mandell, Douglas, and Bennett's principles and practice of infectious diseases. 6th edition vol. 2 (2005), Elsevier Churchill Livingston, Philadelphia 3215-3228
59. Sinigalliano C.D., Gidley M.L., Shibata T., et al. Impacts of hurricanes Katrina and Rita on the microbial landscape of the New Orleans area. Proc Natl Acad Sci USA 104 (2007) 9029-9034 [Epub 2007 May 8]
60. Tumwine J.K., Kekitinwa A., Nabukeera N., et al. Cryptosporidium parvum in children with diarrhea in Mulago Hospital, Kampala, Uganda. Am J Trop Med Hyg 68 (2003) 710-715
61. Abubakar I., Aliyu S.H., Arumugam C., et al. Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis. Br J Clin Pharmacol 63 (2007) 387-393 [Epub 2007 Mar 1]
62. Cleri D.J., Ricketti A.J., Porwancher R.B., et al. Viral hemorrhagic fevers: current status of endemic disease and strategies for control. Infect Dis Clin North Am 20 (2006) 359-393
63. Reynolds M.G., Yorita K.L., Kuehnert M.J., et al. Clinical manifestations of human monkeypox influenced by route of infection. J Infect Dis 194 (2006) 773-780 [Epub 2006 Aug 8]
64. Hutson C.L., Lee K.N., Abel J., et al. Monkeypox zoonotic associations: insights from laboratory evaluation of animals associated with multi-state US outbreak. Am J Trop Med Hyg 76 (2007) 757-768
65. Cunha B.E. Monkeypox in the United States: an occupational health look at the first cases. AAOHN J 52 (2004) 164-168
66. Nalca A., Rimoin A.W., Bavari S., et al. Reemergence of monkeypox: prevalence, diagnostics, and countermeasures. Clin Infect Dis 41 (2005) 1765-171 [Epub 2005 Nov 11]
67. Cleri D.J., Porwancher R.B., Ricketti A.J., et al. Smallpox as a bioterrorist weapon: myth or menace?. Infect Dis Clin North Am 20 (2006) 329-357
68. Rimoin A.W., Kisalu N., Kebela-Ilunga B., et al. Endemic human monkeypox, Democratic Republic of Congo, 2001-2004. Emerg Infect Dis 13 (2007) 934-937
69. Zafar A., Swanepoel R., Hewson R., et al. Nosocomial buffalopoxvirus infection, Karachi, Pakistan. Emerg Infect Dis 13 (2007) 902-904
70. Cleri D.J., Ricketti A.J., and Vernaleo J.R. Colorado tick fever. Infectious Disease Practice for Clinicians 31 (2007) 573-576
71. Watts D.M., Granwehr B.P., Shope R.E., et al. Japanese encephalitis and West Nile and other flavivirus infections. In: Guerrant R.L., Walker D.H., and Weller P.F. (Eds). Tropical infectious diseases-principles, pathogens, practice. 2nd edition vol. 1 (2006), Elsevier Churchill Livingston, Philadelphia 823-830
72. Centers for Disease Control and Prevention. West Nile virus activity-United States, 2006. MMWR Morb Mortal Wkly Rep 56 (2007) 556-559
73. Foppa I.M., and Spielman A. Does reservoir host mortality enhance transmission of West Nile virus?. Theor Biol Med Model 4 (2007) 17 [Epub ahead of print]
74. Platt K.B., Tucker B.J., Halbur P.G., et al. West Nile virus in eastern chipmunks (Tamias striatus) sufficient for infecting different mosquitoes. Emerg Infect Dis 13 (2007) 831-837
75. Stamer S.L. Current risks of transfusion-transmitted agents: a review. Arch Pathol Lab Med 131 (2007) 702-707
76. Solomon T. Exotic and emerging viral encephalitides. Curr Opin Neurol 16 (2003) 411-418
77. Solomon T. Control of Japanese encephalitis. N Engl J Med 355 (2006) 869-871
78. McGovern L.M., Boyce T.G., and Fischer P.R. Congenital infections associated with international travel during pregnancy. J Travel Med 14 (2007) 117-128
79. Kumar R., Tripathi P., Singh S., et al. Clinical features in children hospitalized during the 2005 epidemic of Japanese encephalitis in Uttar Pradesh, India. Clin Infect Dis 43 (2006) 123-131 [Epub 2006 Jun 9]
80. Rayamajhi A., Singh R., Prasad R., et al. Clinico-laboratory profile and outcome of Japanese encephalitis in Nepali children. Ann Trop Paediatr 26 (2006) 293-301
81. German A.C., Myint K.S., Mai N.T., et al. A preliminary neuropathological study of Japanese encephalitis in humans and a mouse model. Trans R Soc Trop Med Hyg 100 (2006) 1135-1145 [Epub 2006 Jun 30]
82. Handique S.K., Das R.R., Barman K., et al. Temporal lobe involvement in Japanese encephalitis: problems in differential diagnosis. AJNR Am J Neuroradiol 27 (2006) 1027-1031
83. Caramello P., Canta F., Balbiano R., et al. Role of intravenous immunoglobulin administration in Japanese encephalitis. Clin Infect Dis 43 (2006) 1620-1621
84. Gould E.A., Higgs S., Buckley A., et al. Potential arbovirus emergence and implications for the United Kingdom. Emerg Infect Dis 12 (2006) 549-555
85. Di Nicuolo G., Pagliano P., Battisti S., et al. Toscana virus central nervous system infections in southern Italy. J Clin Microbiol 43 (2005) 6186-6188
86. Centers for Disease Control and Prevention. Update: Chikungunya fever diagnosed among international travelers-United States, 2006. MMWR Morb Mortal Wkly Rep 56 (2007) 276-277
87. Pialoux G., Gauzere B.A., Jaureguiberry S., et al. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis 7 (2007) 319-327
88. Charrel R.N., de Lamballierie X., and Raolt D. Chikungunya outbreaks-the globalization of vectorborne diseases. N Engl J Med 356 (2007) 769-771
89. Borgherini G., Poubeau P., Staikowsky F., et al. Outbreak of chikungunya on Reunion Island: early clinical laboratory features in 157 adult patients. Clin Infect Dis 44 (2007) 1401-1407 [Epub 2007 Apr 18]
90. Chanana B., Azad R.V., and Nair S. Bilateral macular choroiditis following chikungunya virus infection. Eye 21 (2007) 1020-1021 [Epub ahead of print]
91. Shenk S.H., Ricketti A.J., Muddasir S.M., et al. Rat-bite fevers: Steptobacillus moniliformis and Spirillum minus. Infectious Disease Practice for Clinicians 30 (2006) 509-513
92. Shenk S.H., Ricketti A.J., Muddasir S.M., et al. Rodent associated infectious diseases. Infectious Disease Practice for Clinicians 30 (2006) 527-540
93. Cleri D.J., Ricketti A.J., Panesar M., et al. Plague (Yersinia pestis)-parts I. and II. Infectious Disease Practice for Clinicians 28 (2004) 259-265 271-5
94. Painter J.A., Molbak K., Sonne-Hansen J., et al. Salmonella-based rodenticides and public health. Emerg Infect Dis 10 (2004) 985-987
95. Eilers H., Pernthaler J., Glockner F.O., et al. Culturability and in situ abundance of pelagic bacteria from the North Sea. Appl Environ Microbiol 66 (2000) 3044-3051
96. Taylor K.S., Zoltan T.B., and Achar S.A. Medical illnesses and injuries encountered during surfing. Curr Sports Med Rep 5 (2006) 262-267
97. Woolgar J.D., Cliff G., Nair R., et al. Shark attack: review of 86 consecutive cases. J Trauma 50 (2001) 887-891
98. Buck J.D., Spotte S., and Gadbaw Jr. J.J. Bacteriology of the teeth from a great white shark: potential medical implications for shark bite victims. J Clin Microbiol 20 (1984) 849-851
99. Byard R.W., James R.A., and Heath K.J. Recovery of human remains after shark attack. Am J Forensic Med Pathol 27 (2006) 256-259
100. Shuval H. Estimating the global burden of thalassogenic diseases: human infectious diseases caused by wastewater pollution of the marine environment. J Water Health 1 (2003) 53-64
101. Centers for Disease Control and Prevention. Outbreak of Vibrio parahaemolyticus infection associated with eating raw oysters and clams harvested from Long Island Sound-Connecticut, New Jersey, and New York. 1998. MMWR Morb Mortal Wkly Rep 48 (1999) 48-51
102. Hlady W.G., Mullen R.C., and Hopkin R.S. Vibrio vulnificus from raw oysters: leading cause of reported deaths from foodborne illness in Florida. J Fla Med Assoc 80 (1993) 536-538
103. Samra Y., Shaked Y., Hertz M., et al. Brucellosis: difficulties in diagnosis and a report on 38 cases. Infection 11 (1983) 310-312
104. Baba M.M., Sarkindared S.E., and Brisibe F. Serological evidence of brucellosis among predisposed patients with pyrexia of unknown origin in the north eastern Nigeria. Cent Eur J Public Health 9 (2001) 158-161
105. Shaalan M.A., Memish Z.A., Mahmoud S.A., et al. Brucellosis in children: clinical observations in 115 cases. Int J Infect Dis 6 (2002) 182-186
106. Foster G., MacMillan A.P., Godfroid J., et al. A review of Brucella sp. infection of sea mammals with particular emphasis on isolates from Scotland. Vet Microbiol 90 (2002) 563-580
107. Memish Z.A., and Venkatesh S. Brucellar epididymo-orchitis in Saudi Arabia: a retrospective study of 26 cases and review of the literature. BJU Int 88 (2001) 72-76
108. Wiesli P., Flepp M., and Greminger P. Fever and dry cough in a construction worker from Portugal. Schweiz Rundsch Med Prax 86 (1997) 1215-1219
109. Giannacopoulos I., Eliopoulou M.I., and Ziambaras T. Transplacentally transmitted congenital brucellosis due to Brucella abortus. J Infect 45 (2002) 209-210
110. Gotuzzo E. Brucellosis. In: Guerrant R.L., Walker D.H., and Weller P.F. (Eds). Tropical infectious diseases-principles, pathogens, practice. 2nd edition vol. 1 (2006), Elsevier Churchill Livingston, Philadelphia 463-470
111. Centers for Disease Control and Prevention. Locally acquired mosquito-transmitted malaria: a guide for investigations in the United States. MMWR Morb Mortal Wkly Rep 55 RR13 (2006) 1-9
112. Puente S., Rubio J.M., Subirats M., et al. The use of PCR in the diagnosis of hyper-reactive malarial splenomegaly (HMS). Ann Trop Med Parasitol 94 (2000) 559-563
113. Singh R.K. Hyperreactive malarial splenomegaly in expatriates. Travel Med Infect Dis 5 (2007) 24-29 [Epub 2006 May 18]
114. Greub G., LaScola B., and Raoult D. Amoebae-resisting bacteria isolated from human nasal swabs by amoebal coculture. Emerg Infect Dis 10 (2004) 470-477
115. Greub G., and Raoult D. Microorganisms resistant to free-living amoebae. Clin Microbiol Rev 17 (2004) 413-433
116. Raoult D., La Scola B., and Birtles R. The discovery and characterization of mimivirus, the largest known virus and putative pneumonia agent. Clin Infect Dis 45 (2007) 95-102
117. Barete S., Combes A., de Jonckheere J.F., et al. Fatal disseminated Acanthamoeba lenticulata infection in a heart transplant patient. Emerg Infect Dis 13 (2007) 736-738
118. Kravetz J.D., and Federman D.G. Cat-associated zoonoses. Arch Inern Med 162 (2002) 1945-1952
119. Abe K., Shimokawa H., Kubota T., et al. Myocarditis associated with visceral larva migrans due to Toxocara canis. Intern Med 41 (2002) 706-708
120. Umehara F., Ookatsu H., Hayashi D., et al. MRI studies of spinal visceral larva migrans syndrome. J Neurol Sci 249 (2006) 7-12 [Epub 2006 Jul 3]
121. Oujamaa L., Sibon I., Vital A., et al. Cerebral vasculitis secondary to Toxocara canis and Fasciola hepatica co-infestation. Rev Neurol (Paris) 159 (2003) 447-450
122. Rey P., Bredin C., Carrere C., et al. Toxocariasis mimicking liver tumor. Presse Med 34 (2005) 1715-1716
123. Walker D.H., Maguina C., and Minnick M. Bartonelloses. In: Guerrant R.L., Walker D.H., and Weller P.F. (Eds). Tropical infectious diseases-principles, pathogens, practice. 2nd edition vol. 1 (2006), Elsevier Churchill Livingston, Philadelphia 454-462
124. Eremeeva M.E., Gerns H.L., Lydy S.L., et al. Bacteremia, fever, and splenomegaly caused by a newly recognized Bartonella species. N Engl J Med 356 (2007) 2381-2387
125. Breitschwerdt E.B., and Kordick D.L. Bartonella infection in animals: carriership, reservoir potential, pathogenicity, and zoonotic potential for human infection. Clin Microbiol Rev 13 (2000) 428-438
126. Koehler J.E., Sanchez M.A., Tye S., et al. Prevalence of Bartonella infection among human immunodeficiency virus-infected patients with fever. Clin Infect Dis 37 (2003) 559-566
127. Thudi K.R., Kreikemeier J.T., Phillips N.J., et al. Cat scratch disease causing hepatic masses after liver transplant. Liver Int 27 (2007) 145-148
128. Keynan Y., Yakirevitch E., Shusterman T., et al. Bone marrow and skin granulomatosis in a patient with Bartonella infection. J Med Microbiol 56 (2007) 133-135
129. Malatack J.J., and Jaffe R. Granulomatous hepatitis in three children due to cat-scratch disease without peripheral adenopathy: an unrecognized cause of fever of unknown origin. Am J Dis Child 147 (1993) 949-953
130. Tsuneoka H., and Tsukahara M. Analysis of data in 30 patients with cat scratch disease without lymphadenopathy. J Infect Chemother 12 (2006) 224-226
131. Werner M., Fournier P.E., Andersson R., et al. Bartonella and Coxiella antibodies in 334 prospectively studied episodes of infective endocarditis in Sweden. Scand J Infect Dis 35 (2003) 724-727
132. Silver B.E., and Bean C.S. Cat scratch encephalopathy. Del Med J 63 (1991) 365-368
133. Daye S., McHenry J.A., and Roscelli J.D. Pruritic rash associated with cat scratch disease. Pediatrics 81 (1988) 559-561
134. Brouqui P., and Raoult D. Arthropod-borne diseases in homeless. Ann N Y Acad Sci 1078 (2006) 223-235
135. Rehan N. Profile of men suffering from sexually transmitted infections in Pakistan. J Pak Med Assoc 56 (2006) S60-S65
136. Alvarez W.A., and Freinhar J.P. A prevalence study of bestiality (zoophilia) in psychiatric in-patients, medical in-patients, and psychiatric staff. Int J Psychosom 38 (1991) 45-47
137. English K., Jones L., Patrick D., et al. Sexual offender containment: use of the postconviction polygraph. Ann N Y Acad Sci 989 (2003) 411-427 [discussion 441-445]
138. Jimenez-Jimeniz F.J., Sayed Y., Garcia-Soldevilla M.A., et al. Possible zoophilia associated with dopaminergic therapy in Parkinson disease. Ann Pharmacother 36 (2002) 1178-1179
139. Cleri D.J., Vernaleo J.R., Lombardi L.J., et al. Plague pneumonia disease caused by Yersinia pestis. Semin Respir Infect 12 (1997) 12-23
140. Centers for Disease Control and Prevention. Tuberculosis in imported nonhuman primates-United States, June 1990-May 1993. MMWR Morb Mortal Wkly Rep 42 (1993) 572-576
141. Myers K.P., Setterquist S.F., Capuano A.W., et al. Infection due to 3 avian influenza subtypes in the United States veterinarians. Clin Infect Dis 45 (2007) 4-9
142. Seward J.P. Occupational allergy to animals. Occup Med 14 (1999) 285-304
143. Shuhaiber S., Koren G., Boskovic R., et al. Seroprevalence of Toxoplasma gondii infection among veterinary staff in Ontario, Canada (2002): implications for teratogenic risk. BMC Infect Dis 3 (2003) 8
144. Centers for Disease Control and Prevention. Epidemiologic notes and reports imported bubonic plague-District of Columbia. MMWR Morb Mortal Wkly Rep 39 (1990) 895
145. Centers for Disease Control and Prevention. Imported plague-New York City. 2002. MMWR Morb Mortal Wkly Rep 52 (2003) 725-728
146. Centers for Disease Control and Prevention. Tularemia-United States, 1990-2000. MMWR Morb Mortal Wkly Rep 51 (2002) 181-184
147. Centers for Disease Control and Prevention. Inhalation anthrax associated with dried animal hides-Pennsylvania and New York City, 2006. MMWR Morb Mortal Wkly Rep 55 (2006) 280-282
148. Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related inhalation anthrax-Connecticut, 2001. MMWR Morb Mortal Wkly Rep 50 (2001) 1049-1051
149. Weese J.S., McCarthy L., Mossop M., et al. Observation of practices at petting zoos and the potential impact on zoonotic disease transmission. Clin Infect Dis 45 (2007) 10-15
150. In: Woods J.B. (Ed). USAMRID's medical management of biological casualties handbook. 6th edition (2005), US Army Medical Research Institute of Infectious Diseases, Fort Detrick, Frederick, (MD) p. 7-9, 16-105
151. Rabinowitz P., Gordon Z., Chudnov D., et al. Animals as sentinals of bioterrorism agents. Emerg Infect Dis 12 (2006) 647-652
152. Eddy D.M., and Clanton C.H. The art of diagnosis: solving the clinicopathological exercise. N Engl J Med 306 (1982) 1263-1268